10184 related articles for article (PubMed ID: 11396142)
1. Loss of heterozygosity of gene THW is frequently found in melanoma metastases.
Hildebrandt T; van Dijk MC; van Muijen GN; Weidle UH
Anticancer Res; 2001; 21(2A):1071-80. PubMed ID: 11396142
[TBL] [Abstract][Full Text] [Related]
2. Identification of THW, a putative new tumor suppressor gene.
Hildebrandt T; Preiherr J; Tarbé N; Klostermann S; Van Muijen GN; Weidle UH
Anticancer Res; 2000; 20(5A):2801-9. PubMed ID: 11062687
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity in the MXI1 gene is a frequent occurrence in melanoma.
Ariyanayagam-Baksh SM; Baksh FK; Swalsky PA; Finkelstein SD
Mod Pathol; 2003 Oct; 16(10):992-5. PubMed ID: 14559981
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression of KAI1/CD82 metastasis suppressor gene is associated with loss of heterozygosity in melanoma cell lines.
Kim YI; Shin MK; Lee JW; Chung JH; Lee MH
Oncol Rep; 2009 Jan; 21(1):159-64. PubMed ID: 19082457
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the candidate 8p21 tumour suppressor, BNIP3L, in breast and ovarian cancer.
Lai J; Flanagan J; Phillips WA; Chenevix-Trench G; Arnold J
Br J Cancer; 2003 Jan; 88(2):270-6. PubMed ID: 12610513
[TBL] [Abstract][Full Text] [Related]
6. Loss of expression of the metastasis suppressor gene KiSS1 during melanoma progression and its association with LOH of chromosome 6q16.3-q23.
Shirasaki F; Takata M; Hatta N; Takehara K
Cancer Res; 2001 Oct; 61(20):7422-5. PubMed ID: 11606374
[TBL] [Abstract][Full Text] [Related]
7. TTC4, a novel candidate tumor suppressor gene at 1p31 is often mutated in malignant melanoma of the skin.
Poetsch M; Dittberner T; Cowell JK; Woenckhaus C
Oncogene; 2000 Nov; 19(50):5817-20. PubMed ID: 11126369
[TBL] [Abstract][Full Text] [Related]
8. Deletion mapping suggests that the 1p22 melanoma susceptibility gene is a tumor suppressor localized to a 9-Mb interval.
Walker GJ; Indsto JO; Sood R; Faruque MU; Hu P; Pollock PM; Duray P; Holland EA; Brown K; Kefford RF; Trent JM; Mann GJ; Hayward NK
Genes Chromosomes Cancer; 2004 Sep; 41(1):56-64. PubMed ID: 15236317
[TBL] [Abstract][Full Text] [Related]
9. Expression and Up-regulation of alternatively spliced transcripts of melastatin, a melanoma metastasis-related gene, in human melanoma cells.
Fang D; Setaluri V
Biochem Biophys Res Commun; 2000 Dec; 279(1):53-61. PubMed ID: 11112417
[TBL] [Abstract][Full Text] [Related]
10. An 800-kb region of deletion at 13q14 in human prostate and other carcinomas.
Chen C; Frierson HF; Haggerty PF; Theodorescu D; Gregory CW; Dong JT
Genomics; 2001 Oct; 77(3):135-44. PubMed ID: 11597138
[TBL] [Abstract][Full Text] [Related]
11. Allele-specific loss of heterozygosity at the DAL-1/4.1B (EPB41L3) tumor-suppressor gene locus in the absence of mutation.
Kittiniyom K; Mastronardi M; Roemer M; Wells WA; Greenberg ER; Titus-Ernstoff L; Newsham IF
Genes Chromosomes Cancer; 2004 Jul; 40(3):190-203. PubMed ID: 15138999
[TBL] [Abstract][Full Text] [Related]
12. Mutational and functional analyses reveal that ST7 is a highly conserved tumor-suppressor gene on human chromosome 7q31.
Zenklusen JC; Conti CJ; Green ED
Nat Genet; 2001 Apr; 27(4):392-8. PubMed ID: 11279520
[TBL] [Abstract][Full Text] [Related]
13. Molecular cloning and characterization of LCRG1 a novel gene localized to the tumor suppressor locus D17S800-D17S930.
Li Y; Chen Z
Cancer Lett; 2004 Jun; 209(1):75-85. PubMed ID: 15145523
[TBL] [Abstract][Full Text] [Related]
14. Characterization of copine VII, a new member of the copine family, and its exclusion as a candidate in sporadic breast cancers with loss of heterozygosity at 16q24.3.
Savino M; d'Apolito M; Centra M; van Beerendonk HM; Cleton-Jansen AM; Whitmore SA; Crawford J; Callen DF; Zelante L; Savoia A
Genomics; 1999 Oct; 61(2):219-26. PubMed ID: 10534407
[TBL] [Abstract][Full Text] [Related]
15. LAPSER1: a novel candidate tumor suppressor gene from 10q24.3.
Cabeza-Arvelaiz Y; Thompson TC; Sepulveda JL; Chinault AC
Oncogene; 2001 Oct; 20(46):6707-17. PubMed ID: 11709705
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic inactivation of RAS association domain family protein 1 (RASSF1A) in malignant cutaneous melanoma.
Spugnardi M; Tommasi S; Dammann R; Pfeifer GP; Hoon DS
Cancer Res; 2003 Apr; 63(7):1639-43. PubMed ID: 12670917
[TBL] [Abstract][Full Text] [Related]
17. CBFA2T3 (MTG16) is a putative breast tumor suppressor gene from the breast cancer loss of heterozygosity region at 16q24.3.
Kochetkova M; McKenzie OL; Bais AJ; Martin JM; Secker GA; Seshadri R; Powell JA; Hinze SJ; Gardner AE; Spendlove HE; O'Callaghan NJ; Cleton-Jansen AM; Cornelisse C; Whitmore SA; Crawford J; Kremmidiotis G; Sutherland GR; Callen DF
Cancer Res; 2002 Aug; 62(16):4599-604. PubMed ID: 12183414
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity on chromosomes 3, 9, 13, and 17, including the retinoblastoma locus, in uveal melanoma.
Scholes AG; Liloglou T; Maloney P; Hagan S; Nunn J; Hiscott P; Damato BE; Grierson I; Field JK
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2472-7. PubMed ID: 11581185
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide loss of heterozygosity and copy number analysis in melanoma using high-density single-nucleotide polymorphism arrays.
Stark M; Hayward N
Cancer Res; 2007 Mar; 67(6):2632-42. PubMed ID: 17363583
[TBL] [Abstract][Full Text] [Related]
20. Defining the region(s) of deletion at 6q16-q22 in human prostate cancer.
Hyytinen ER; Saadut R; Chen C; Paull L; Koivisto PA; Vessella RL; Frierson HF; Dong JT
Genes Chromosomes Cancer; 2002 Jul; 34(3):306-12. PubMed ID: 12007191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
